11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
In a surprising decision, the California Supreme Court has ruled that Plaintiffs in Private Attorney...
Read More >
On June 13, 2019, the Eighth Circuit affirmed the district court’s grant of a preliminary injunctio...
Read More >
Workplace Changes for Workers in the Screen Industry Proposed Bill or Initiative - Key changes in N...
Read More >
Before practicing law, I had another life. I was a 20-something trying to make my way in Hollywood—...
Read More >
The Empire State Development Corporation (“ESDC”) issued guidance over the weekend clarifying the ...
Read More >
The new National Security and Investment Bill, which aims to provide the Government with the necessa...
Read More >